Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2003 pubmed

Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.

Schauber. J J; Svanholm. C C; Termén. S S; Iffland. K K; Menzel. T T; Scheppach. W W; Melcher. R R; Agerberth. B B; Lührs. H H; Gudmundsson. G H GH

Key Findings

  • Butyrate, propionate and isobutyrate increase LL‑37 expression in colon cells
  • LL‑37 increase is tied to cell differentiation measured by alkaline phosphatase activity
  • MEK inhibition blocks LL‑37 rise while p38 inhibition blocks differentiation but not LL‑37

Practical Outcomes

  • Eating more fiber that feeds gut bacteria to make SCFA, or taking a butyrate supplement, may enhance gut antimicrobial defenses via higher LL‑37 levels. This effect appears independent of other differentiation pathways, so it’s a relatively direct way to support mucosal immunity.

Summary

The study shows that short‑chain fatty acids (like butyrate, propionate and isobutyrate) boost the gut’s natural antimicrobial peptide LL‑37 in colon cells, and this boost is linked to cell maturation. Different signaling pathways control LL‑37 production and cell differentiation, meaning you can raise LL‑37 without necessarily changing how the cells mature.

Abstract

Short chain fatty acids (SCFA) exert profound effects on the colonic mucosa. In particular, SCFA modulate mucosal immune functions. The antimicrobial cathelicidin LL-37 is expressed by colon epithelial cells. In the present study the effect of SCFA on LL-37 expression was investigated. LL-37 expression in vivo was assessed by immunohistochemistry. Real time quantitative reverse transcription-polymerase chain reaction was employed to determine LL-37 expression in colonocytes in vitro after treatment with various cytokines, SCFA, or flavone. LL-37 levels were correlated to cell differentiation which was determined by alkaline phosphatase (AP) activity. In addition, intracellular signalling pathways such as MEK-ERK (mitogen/extracellular signal protein kinase (MEK)/extracellular signal regulated protein kinase (ERK)) and p38/mitogen activated protein (MAP) kinase were explored. In vivo, LL-37 expression in healthy mucosa was restricted to differentiated epithelial cells in human colon and ileum. In colonocytes, increased LL-37 expression associated with cell differentiation was detected in vitro following treatment with butyrate, isobutyrate, propionate, and trichostatin A. Flavone induced LL-37 transcription but did not affect AP activity while cytokines had no effect. To dissect pathways mediating differentiation and LL-37 expression, specific inhibitors were applied. Inhibition of the protein kinase MEK enhanced butyrate induced AP activity while LL-37 expression in colon epithelial cells was blocked. In contrast, inhibition of p38/MAP kinase blocked cell differentiation without inhibiting LL-37 expression. Expression of the cathelicidin LL-37 in colonocytes and cellular differentiation are separately modulated by SCFA via distinct signalling pathways. These data may provide a rationale for dietary modulation of mucosal defence mechanisms.

Study Information

Provider

pubmed

Year

2003

DOI

10.1136/gut.52.5.735